Domenic Abbondanza

Domenic Abbondanza

Auto-generated profile, based on publicly available information

Domenic Abbondanza

Spatial Technology Platform, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2021 in Nature
Verified
Journal Article
Closed access
PDF file
TDToni M. Delorey
Toni M. Delorey
CZCarly G. K. Ziegler
Carly G. K. Ziegler
GHGraham Heimberg
Graham Heimberg
RNRachelly Normand
Rachelly Normand
YYYiming Yang
Yiming Yang
ARAviv Regev
Aviv Regev

28 July 2022 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
WHWilliam L. Hwang
William L. Hwang
KJKarthik A. Jagadeesh
Karthik A. Jagadeesh
JGJimmy A. Guo
Jimmy A. Guo
HHHannah I. Hoffman
Hannah I. Hoffman
PYPayman Yadollahpour
Payman Yadollahpour
ARAviv Regev
Aviv Regev

24 January 2025 in Science Immunology
Verified
Journal Article
Closed access
KMKatie Maurer
Katie Maurer
CPCameron Y. Park
Cameron Y. Park
SMShouvik Mani
Shouvik Mani
MBMehdi Borji
Mehdi Borji
FRFlorian Raths
Florian Raths
EAElham Azizi
Elham Azizi
Understanding how intratumoral immune populations coordinate antitumor responses after therapy can guide treatment prioritization. We systematically analyzed an established immunotherapy, donor lymphocyte infusion (DLI), by assessing 348,905 single-cell transcriptomes from 74 longitudinal bone marrow samples of 25 patients with relapsed leukemia; a subset was evaluated by both protein- and transcriptome-based spatial analysis. In acute myeloid leukemia (AML) DLI responders, we identified clonally expanded ZNF683 + CD8 + cytotoxic T lymphocytes with in vitro specificity for patient-matched AML. These cells originated primarily from the DLI product and appeared to coordinate antitumor immune responses through interaction with diverse immune cell types within the marrow microenvironment. Nonresponders lacked this cross-talk and had cytotoxic T lymphocytes with elevated TIGIT expression. Our study identifies recipient bone marrow microenvironment differences as a determinant of an effective antileukemia response and opens opportunities to modulate cellular therapy.

16 March 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
DSDenis Schapiro
Denis Schapiro
ASArtem Sokolov
Artem Sokolov
CYClarence Yapp
Clarence Yapp
JMJeremy L Muhlich
Jeremy L Muhlich
JHJoshua Hess
Joshua Hess
PSPeter K. Sorger
Peter K. Sorger
Highly multiplexed tissue imaging makes molecular analysis of single cells possible in a preserved spatial context. However, reproducible analysis of the underlying data poses a substantial computational challenge. Here we describe a modular and open-source computational pipeline (MCMICRO) for performing the sequential steps needed to transform large, multi-channel whole slide images into single-cell data. We demonstrate use of MCMICRO on images of different tissues and tumors acquired using multiple imaging platforms, thereby providing a solid foundation for the continued development of tissue imaging software.

1 November 2023 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CMChristine M. McIntosh
Christine M. McIntosh
JAJennifer B. Allocco
Jennifer B. Allocco
PWPeter Wang
Peter Wang
MMMichelle L McKeague
Michelle L McKeague
ACAlexandra Cassano
Alexandra Cassano
MAMaria-Luisa Alegre
Maria-Luisa Alegre
Even when successfully induced, immunological tolerance to solid organs remains vulnerable to inflammatory insults, which can trigger rejection. In a mouse model of cardiac allograft tolerance in which infection with Listeria monocytogenes (Lm) precipitates rejection of previously accepted grafts, we showed that recipient CD4+ TCR75 cells reactive to a donor MHC class I–derived peptide become hypofunctional if the allograft is accepted for more than 3 weeks. Paradoxically, infection-induced transplant rejection was not associated with transcriptional or functional reinvigoration of TCR75 cells. We hypothesized that there is heterogeneity in the level of dysfunction of different allospecific T cells, depending on duration of their cognate antigen expression. Unlike CD4+ TCR75 cells, CD4+ TEa cells specific for a peptide derived from donor MHC class II, an alloantigen whose expression declines after transplantation but remains inducible in settings of inflammation, retained function in tolerant mice and expanded during Lm-induced rejection. Repeated injections of alloantigens drove hypofunction in TEa cells and rendered grafts resistant to Lm-dependent rejection. Our results uncover a functional heterogeneity in allospecific T cells of distinct specificities after tolerance induction and reveal a strategy to defunctionalize a greater repertoire of allospecific T cells, thereby mitigating a critical vulnerability of tolerance.

19 November 2026 in Journal of Clinical Investigation
Verified
Journal Article
Open access
ACAlexandra Cassano
Alexandra Cassano
DADomenic Abbondanza
Domenic Abbondanza
YWYing Wang
Ying Wang
SWShuang Wu
Shuang Wu
CMChristine M. McIntosh
Christine M. McIntosh
MAMaria L. Alegre
Maria L. Alegre
Donor-specific transplantation tolerance promises to free recipients from complications associated with lifelong immunosuppression. Anergy, a CD4 + conventional T cell (Tconv)-intrinsic state of long-term hypofunction, is thought to arise when T cells encounter cognate antigen in the absence of costimulation. Anti-CD154 (αCD154), an antibody that blocks T cell costimulation and is currently in clinical trials, can induce donor-specific transplantation tolerance in mice in association with anergy of Tconvs recognizing persistently expressed alloantigens. Using murine models of fully mismatched cardiac allograft tolerance or repeated alloantigen exposure, we demonstrate that αCD154 is not sufficient and regulatory T cells (Tregs) are necessary to induce and sustain αCD154-mediated alloreactive Tconv anergy. Transient depletion of Tregs disrupted the induction of αCD154-mediated Tconv anergy, and in mice with established tolerance, Treg depletion transcriptionally and functionally reinvigorated previously anergic Tconvs. Mechanistically, Treg depletion increased IL-2 availability and IL-2R signaling in Tconvs, and exogenous IL-2 could bypass Treg-mediated control to partially restore Tconv function. Thus, the state of αCD154-mediated Tconv anergy is less cell-intrinsic than previously thought and requires Tregs to limit IL-2 availability for both its induction and its continuous enforcement. Selecting immunosuppressive drugs that preserve this Treg function may be critical for achieving stable clinical transplantation tolerance.